Ashland Sets Fiscal 2027 Guidance with Projected Sales up to $1.975B and Increased CapEx
Ashland (ASH) has issued its financial guidance for fiscal 2027, projecting annual sales between $1.905 billion and $1.975 billion. The company also expects adjusted EBITDA to fall within the range of $405 million to $435 million. To support these targets, Ashland plans to increase capital expenditures up to $140 million. Management reported a strong close to fiscal 2026, driven by robust commercial performance in key segments. Specifically, Life Sciences sales grew by 4% and Personal Care sales increased by 8%. The company's strategic focus remains on its core specialty segments as it prepares for the upcoming fiscal year.
Tickers: $ASH
Topics: earnings report fiscal year results segment performance
Read the full article at Seeking Alpha
Part of the story Ashland Inc. Reports Q4 2026 Results with Growth in Life Sciences and Personal Care (4 articles)